The response to imatinib and interferon-α is more rapid than the response to imatinib alone: a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase

Before the introduction of imatinib, interferon α-based regimens were the gold standard for treatment of early chronic phase chronic myeloid leukemia patients. The combination of IFN-α with imatinib is currently being investigated in at least two large clinical trials, the German CML Study IV and th...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Palandri, Francesca, Castagnetti, Fausto, Iacobucci, Ilaria, Martinelli, Giovanni, Amabile, Marilina, Gugliotta, Gabriele, Poerio, Angela, Testoni, Nicoletta, Breccia, Massimo, Bocchia, Monica, Crugnola, Monica, Rege-Cambrin, Giovanna, Martino, Bruno, Pierri, Ivana, Radaelli, Franca, Specchia, Giorgina, Pane, Fabrizio, Saglio, Giuseppe, Rosti, Gianantonio, Baccarani, Michele
Médium: Artigo
Jazyk:Inglês
Vydáno: Ferrata Storti Foundation 2010
Témata:
Brief Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2913092/
https://ncbi.nlm.nih.gov/pubmed/20305139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2009.021246
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky